Skip to main content
. Author manuscript; available in PMC: 2013 Dec 1.
Published in final edited form as: Ann Neurol. 2012 Oct 17;72(6):918–926. doi: 10.1002/ana.23693

Figure 5. NG2-Postive Oligodendrocyte Progenitor Cells in Subpial Cortical Lesions.

Figure 5

Oligodendrocyte progenitor cell density is not decreased in subpial-cortical lesions of MS. PLP immunoreactivity in cerebral cortex is shown from a control subject (Panel A), normal-appearing cortex from a patient with MS (Panel B), and a subpial lesion with no evidence of remyelination (Panel C). Panels D, E and F represent NG2 immunohistochemistry in sections cut adjacent to those in Panels A, B and C, respectively. NG2-positive oligodendrocyte progenitor cells are observed in all areas. Arrows indicate NG2-positive cell bodies; arrowheads indicate NG2-positive cells of blood vessels. The scale bars represents 50 μm.